Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by stockman75on May 13, 2021 11:01am
90 Views
Post# 33191458

RE:RE:RE:Evil or incompetent?

RE:RE:RE:Evil or incompetent?Ahh more of the same. Par for the course as expected. So sad. They should be embarrassed. At least make up for it by scheduling a makeup meeting and allow shareholders to ask questions. No wonder we can't get proper valuation they won't or can't even figure out how to communicate!!

SPCEO1 wrote: I voted for them because they responded professionally to our desire they meet with Wino to discuss our issues and because this is, after all, the same board that brought us, in a very economical fashion, both the cancer and NASH opportunities, which is the main reason we are all still even here. 

Still, the consistency of the problems the company faces on so many very basic issues is pretty alarming. I had a conference call with Paul and my clients last Fall and that too was a technical disaster. I really don't think these things are that hard to get right. Worst of all, here we are talking about that instead of the progress the company is having on cancer and/or NASH. 

You can't waste such opportunities to get your message out over and over again. You just can't.

scarlet1967 wrote: I hope you are still happy to vote for the entire "incompetent" board.
SPCEO1 wrote: Clearly, it would be evil to make sure no one could ask any questions by having the portal not work for shareholders. But I don't think they are evil, so that leaves only one obvious alternative.

 




<< Previous
Bullboard Posts
Next >>